Johnson & Johnson (JNJ) reaches agreement with US government to improve medicine access and reduce costs for millions of Americans

Johnson & Johnson's agreement with the U.S.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

Chinese Inflation Rate MoM (Dec) M/M 0.2% vs. Exp. 0.0% (Prev. -0.1%)

Chinese PPI YoY (Dec) Y/Y -1.9% vs. Exp. -2% (Prev. -2.2%)

Johnson & Johnson (JNJ) reaches agreement with US government to improve medicine access and reduce costs for millions of Americans

PBoC injects CNY 34.0bln via 7-day reverse repos with the rate at 1.40%, while operations this week results in a net drain of CNY 1.655tln

PBoC sets USD/CNY mid-point at 7.0128 vs exp. 6.9832 (Prev. 7.0197)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

government to enhance medicine access and lower costs is a significant step towards addressing healthcare affordability. This partnership could improve JNJ's reputation and potentially boost sales, while also affecting the broader pharmaceutical landscape by pressuring peers to adjust their pricing strategies. Watch for any implications on JNJ's financials and how this might resonate through the sector.

Related headlines

The whole workspace, free to try.

Try it free